美晨科技(300237.SZ):選舉劉子傳爲董事長
格隆匯3月5日丨美晨科技(300237.SZ)公佈,公司原董事長、非獨立董事孫來華先生因工作需要,已申請辭去公司董事長、董事、董事會審計委員會委員、董事會戰略委員會委員相關職務,辭任後孫來華先生不再在公司擔任其他職務。
經公司2025年第一次臨時股東大會審議通過,選舉劉子傳先生擔任公司第六屆董事會非獨立董事,任期自股東大會審議通過之日起至第六屆董事會屆滿之日止。
經公司董事會提名委員會提名,董事會選舉劉子傳先生擔任公司新任董事長,同時由劉子傳先生擔任董事會審計委員會委員、董事會戰略委員會委員職務,任期與第六屆董事會非獨立董事任期一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.